SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-13-305910
Filing Date
2013-07-29
Accepted
2013-07-29 06:15:34
Documents
5
Period of Report
2013-07-28
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d574700d8k.htm 8-K 16574
2 EX-99.1 d574700dex991.htm EX-99.1 33697
3 EX-99.2 d574700dex992.htm EX-99.2 28450
4 GRAPHIC g574700ex99_2s1gbgd.jpg GRAPHIC 38794
5 GRAPHIC g574700g63m97.jpg GRAPHIC 6533
  Complete submission text file 0001193125-13-305910.txt   142816
Mailing Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8
Business Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8 514-744-6792
Valeant Pharmaceuticals International, Inc. (Filer) CIK: 0000885590 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A8 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-14956 | Film No.: 13991000
SIC: 2834 Pharmaceutical Preparations